Kazia Therapeutics (KZIA) Current Leases (2017 - 2018)
Kazia Therapeutics (KZIA) posted Current Leases of $63591.1 for Q2 2018, up 746.52% on a QoQ basis from $7512.1 in Q2 2017, and up 746.52% year-over-year from $7512.1 in Q2 2017.
Kazia Therapeutics (KZIA) has 2 years of Current Leases data on file, last reported at $63591.1 in Q2 2018.
- In Q2 2018, Current Leases rose 746.52% year-over-year to $63591.1; the TTM figure through Jun 2018 stood at $63591.1 (up 746.52% YoY), while the FY2018 annual figure was $63591.1, up 746.52% from the prior year.
- Current Leases rose to $63591.1 in Q2 2018, from $7512.1 in the prior quarter.
- Across five years, Current Leases topped out at $63591.1 in Q2 2018 and bottomed at $7512.1 in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 63,591.10 |
| Jun 30, 2017 | 7,512.10 |